4.56
Prime Medicine Inc (PRME) 最新ニュース
Prime Medicine appoints Matthew Hawryluk as chief business officer - Investing.com
Prime Medicine, Inc. Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer - Quiver Quantitative
Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer - The Globe and Mail
Prime Medicine (NASDAQ: PRME) names Matthew Hawryluk CBO; >$2.5B in deals at Gritstone - Stock Titan
Why Prime Medicine Inc. stock appeals to analystsMarket Movement Recap & Weekly Market Pulse Alerts - newser.com
Will Prime Medicine Inc. stock outperform growth indexesMarket Growth Report & Low Drawdown Momentum Trade Ideas - newser.com
Is Prime Medicine Inc. stock a buy in volatile markets2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com
Price momentum metrics for Prime Medicine Inc. explainedMarket Risk Summary & Daily Market Momentum Tracking - newser.com
Is Prime Medicine Inc. stock supported by strong fundamentalsJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com
How Prime Medicine Inc. stock reacts to job market data2025 Momentum Check & Expert Curated Trade Setup Alerts - newser.com
How Prime Medicine Inc. stock performs in weak economyJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com
Momentum divergence signals in Prime Medicine Inc. chartMarket Trend Summary & Verified Swing Trading Watchlists - newser.com
Technical signs of recovery in Prime Medicine Inc.Market Risk Summary & Technical Confirmation Alerts - newser.com
Prime Medicine’s Price Target Revision Sparks Market Interest - StocksToTrade
Prime Medicine Eyes Expansion with Strategic Partnerships and Investor Engagement - timothysykes.com
Prime Medicine, Inc. (NYSE:PRME) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Prime Medicine’s Investor Activities and Upcoming Developments Boost Market Interest - StocksToTrade
Prime Medicine Stock Poised for Strategic Growth With New Developments - timothysykes.com
Prime Medicine (NASDAQ:PRME) Shares Up 9.9%Time to Buy? - MarketBeat
Prime Medicine (NYSE:PRME) Trading 11.9% HigherWhat's Next? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $3.94 Million Position in Prime Medicine, Inc. $PRME - MarketBeat
How institutional ownership impacts Prime Medicine Inc. stock2025 Big Picture & Safe Capital Growth Tips - newser.com
PRME Stock Surge: A Buying Opportunity? - StocksToTrade
Institutional investors in Prime Medicine, Inc. (NASDAQ:PRME) see US$174m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance
Does Prime Medicine Inc. qualify in momentum factor screeningEarnings Beat & Weekly High Potential Stock Alerts - newser.com
Combining price and volume data for Prime Medicine Inc.Portfolio Value Summary & Weekly Chart Analysis and Trade Guides - newser.com
Using economic indicators to assess Prime Medicine Inc. potentialWeekly Profit Report & AI Based Buy and Sell Signals - newser.com
IQ EQ FUND MANAGEMENT IRELAND Ltd Reduces Stock Holdings in Prime Medicine, Inc. $PRME - MarketBeat
Published on: 2025-10-31 03:29:26 - newser.com
Smart tools for monitoring Prime Medicine Inc.’s price actionJuly 2025 Snapshot & AI Forecasted Stock Moves - newser.com
Comparing Prime Medicine Inc. in custom built stock radarsMarket Performance Recap & Stock Portfolio Risk Management - newser.com
Can Prime Medicine Inc. stock outperform in 2025 bull marketTrend Reversal & Daily Technical Forecast Reports - newser.com
Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy - The Manila Times
Prime Medicine (NASDAQ: PRME) to file IND/CTA for PM577 in H1 2026 for Wilson’s Disease - Stock Titan
News impact scoring models applied to Prime Medicine Inc.Weekly Trade Review & Real-Time Volume Analysis - newser.com
Prime Medicine Update Reveals Latest Trends in Healthcare Stocks - Kalkine Media
Prime Medicine (NASDAQ:PRME) Trading Down 5.8%Here's Why - MarketBeat
Prime Medicine (NYSE:PRME) Stock Price Down 6.5%Here's Why - MarketBeat
Prime Medicine (NYSE:PRME) Shares Gap DownShould You Sell? - MarketBeat
大文字化:
|
ボリューム (24 時間):